Aleglitazar Pages on BioPortfolio:

BioPortfolio - Aleglitazar
BioPortfolio - Olivary Nucleus - InDepth A Study of Aleglitazar in Patients ... BioPortfolio slp trials A Comparative Study of Aleglitazar and Actos® in . ...
http://www.bioportfolio.com/search/Aleglitazar_.html...

BioPortfolio - olivary nucleus
BioPortfolio - Olivary Nucleus - InDepth A Study of Aleglitazar in Patients . .. . Recent Search Terms used to find this page: olivary nucleus . ...
http://www.bioportfolio.com/search/olivary_nucleus.html...

BioPortfolio - CETP
BioPortfolio - Aleglitazar CETP inh. - dyslipidaemia. ocrelizumab - RRMS ... Political defibrillator Aleglitazar (R1439). PPAR agonist. ...
http://www.bioportfolio.com/search/CETP.html...

BioPortfolio - alefacept
Codes Terminology C65220 ALEFACEPT FDA C63923 FDA Established Names and Unique Ingredient Identifier Codes Terminology C72687 ALEGLITAZAR FDA C63923 FDA . ...
http://www.bioportfolio.com/search/alefacept.html...

BioPortfolio - cetp
BioPortfolio - Aleglitazar CETP inh. - dyslipidaemia. ocrelizumab - RRMS . ... http://www.bioportfolio.com/search/cetp.html... BioPortfolio - Biocentury PDF
...
http://www.bioportfolio.com/search/cetp.html...

BioPortfolio - slp
BioPortfolio slp trials A Comparative Study of Aleglitazar and Actos® in Patients With Type 2 ... http://www.bioportfolio.com/gene/2610350-slp/trials.
html. ...
http://www.bioportfolio.com/search/slp.html...

BioPortfolio - pparg DT2
BioPortfolio - Aleglitazar 2nd- generation selective PPAR gamma modulator. Ph IIa. sanofi-aventis. .... England & Wales at Wessex Barn, Dorchester Road, ...
http://www.bioportfolio.com/search/pparg__DT2_.html...

BioPortfolio - metabolex ppar 2008
BioPortfolio - Aleglitazar Metabolex/J&J. MBX-2044. 2nd- generation selective PPAR gamma modulator. ... Page 1 Investor science event at ADA 2008 San ...
http://www.bioportfolio.com/search/metabolex_ppar_2008.html...

Search - 0916856186 - Alcoholics Anonymous
BioPortfolio - Aleglitazar ftp://anonymous@ftp1.nci.nih.gov/pub/cacore/EVS/FDA/ FDA_NCIt... FDA Subsets 2972, FDA, C63923, FDA Established Names and Unique ...
http://www.bioportfolio.com/bookshop/SearchIndex/Books/Opera...

Results from other life science and pharmaceutical sites:

Roche - Metabolic Disorders
Additional candidate molecules include R1439 (aleglitazar) in phase II; and R7201 (co-development by Roche and Chugai) and R1511, both in phase I. These ...
http://www.roche.com/research_and_development/r_d_overview/p...

FDA UNII Code (use for SPL) FDA Preferred Term NCI Concept Code ...
... C47385 3K9958V90M ALCOHOL C2190 4964P6T9RB ALDOSTERONE C219 ELK3V90G6C ALEFACEPT C65220 41T4OAG59U ALEGLITAZAR C72687 2UY4M2U3RA ALENDRONATE SODIUM
C973 ...
ftp://anonymous@ftp1.nci.nih.gov/pub/cacore/EVS/FDA/UNII/FDA...

Beyond the deal
aleglitazar - type 2 diabetes. DPP-IV (3) - type 2 diabetes. GLP1 - type 2 diabetes. CETP inh. - dyslipidaemia. ocrelizumab - RRMS ...
http://www.roche.com/partnering_with_roche.pdf...

FDA UNII Subset
144, 41T4OAG59U, ALEGLITAZAR, C72687. 145, 2UY4M2U3RA, ALENDRONATE SODIUM, C973. 146, X1J18R4W8P, ALENDRONIC ACID, C61625. 147, R6G1M06TPO, ALEPRIDE, C74450 ...
ftp://anonymous@ftp1.nci.nih.gov/pub/cacore/EVS/FDA/UNII/FDA...

R+D pipeline – improvements in quality and focus
(aleglitazar). dual PPAR agonist. type 2 diabetes. II. metabolic diseases. R1579 . DPP-IV inhibitor. type 2 diabetes. II. R1583. GLP-1 analogue ...
http://www.roche.com/gb07erd.pdf...

Page 1 Investor science event at ADA 2008 San Francisco, 9 June ...
Aleglitazar (R1439) dual α-γ. PPAR agonist (phase II). →. Additional 4 phase I compounds. in diabetes ..... Aleglitazar (R1439) PPAR co-agonist. • Phase II ...
http://www.roche.com/irp080609.pdf...

Political defibrillator
Aleglitazar (R1439). PPAR agonist. Ph II. Metabolex/J&J. MBX-2044. 2nd- generation selective PPAR gamma modulator. Ph IIa. sanofi-aventis. AVE8134 ...
http://www.cceb.upenn.edu/news/BioCentury.pdf...

Source Subset Code Subset Name Concept Code Source PT Source ...
... Codes Terminology C65220 ALEFACEPT FDA C63923 FDA Established Names and Unique Ingredient Identifier Codes Terminology C72687 ALEGLITAZAR FDA C63923 FDA
...
ftp://anonymous@ftp1.nci.nih.gov/pub/cacore/EVS/FDA/FDA_NCIt...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.